<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00613795</url>
  </required_header>
  <id_info>
    <org_study_id>03-13013</org_study_id>
    <nct_id>NCT00613795</nct_id>
  </id_info>
  <brief_title>Lactobacillus GG in the Prophylaxis of Ventilator Associated Pneumonia</brief_title>
  <official_title>Lactobacillus GG in the Prophylaxis of Ventilator Associated Pneumonia: A Prospective, Randomized, Placebo-controlled, Double-blind Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Creighton University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Creighton University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study utilizes lactobacillus, or probiotics, delivered twice daily to the mouth and
      stomach, via feeding tube, in effort to determine whether the oral administration of a
      naturally occurring Lactobacillus species reduces the incidence of ventilator associated
      pneumonia therefore reducing intensive care unit(ICU)complications.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The long-term objective of this research is to determine the utility of altering the oral and
      gastric bacterial flora in mechanically ventilated patients in order to reduce intensive care
      unit (ICU)complications. Specifically, our goal is to determine whether the oral
      administration of a naturally occurring Lactobacillus species reduces the incidence of
      ventilator associated pneumonia (VAP). ICU admission is commonly accompanied by overgrowth of
      the natural gastrointestinal (GI) and oropharyngeal flor by pathogenic organisms. Patients
      requiring endotracheal intubation are predisposed to developing VAP, presumably via
      micro-aspiration of the altered oropharyngeal flora. By reducing VAP rates, we hope to
      improve ICU outcomes, minimize ICU expenses, and most importantly, decrease morbidity and
      mortality.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2004</start_date>
  <completion_date type="Actual">November 2009</completion_date>
  <primary_completion_date type="Actual">August 2009</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To determine whether patients given oral Lactobacillus GG will have a smaller increase in the density of pathogenic bacterial in cultures from oral swabs, nasogastric aspirates, and minimally invasive bronchoalveolar lavage samples.</measure>
    <time_frame>daily while intubated</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>To assess whether administration of Lactobacillus GG to intubated patients reduces clinically diagnosed VAP,reduces microbiologically diagnosed VAP, affects mortality and duration of mechanical ventilation, and total antibiotic consumption.</measure>
    <time_frame>daily while intubated</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">125</enrollment>
  <condition>Pneumonia</condition>
  <condition>Ventilator Associated Pneumonia</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Lactobacillus</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Lactobacillus GG</intervention_name>
    <description>Every 12 hours, the contents of a single capsule containing Lactobacillus GG will be suspended in 3 ml of water-soluble jelly. The suspension will be applied to the oropharyngeal mucosa via sterile syringe. The contents of a second capsule will be suspended in 10 ml of sterile water and pushed through the NG tub followed by 10 mL of air to ensure complete administration.</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>Every 12 hours, the contents of a single identical placebo capsule containing the inert plant carbohydrate inulin will be suspended in 3 ml of water-soluble jelly. This suspension will be applied to the oropharyngeal mucosa via sterile syringe. The contents of a second placebo capsule will be suspended in 10 ml of sterile water and pushed through eh NG tube followed by 10 mL of air to ensure complete administration</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Admission to the medical, surgical, or cardiac ICU

          -  Age 19 years or greater (the age of majority in the state of Nebraska)

          -  Anticipated need for &gt;72 hours of endotracheal intubation

          -  Initial intubation during hospitalization

          -  Approval of the attending physician responsible for the patient's care

          -  Informed surrogate consent within 24 hours of intubation

        Exclusion Criteria:

          -  Pregnancy

          -  Pharmacologic immunosuppression (&gt;10mg prednisone daily or equivalent for at least 14
             days)

          -  Native immunosuppression: 1)known HIV disease or AIDS, 2)history of malignancy,
             3)multiple organ system failure

          -  History of prosthetic or bioprosthetic cardiac valve placement

          -  History of prosthetic vascular graft placement

          -  Cardiac trauma

          -  History of rheumatic fever, endocarditis, congenital cardia abnormality, or acquired
             cardia abnormality

          -  Gastroesophageal surgery or perforation associated with current admission

          -  Intestinal surgery or perforation associated with current admission

          -  Significant oropharyngeal mucosal injury

          -  Placement of a tracheostomy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lee Morrow, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistant Professor of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Creighton University Medical Center</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68131</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Atherton ST, White DJ. Stomach as source of bacteria colonising respiratory tract during artificial ventilation. Lancet. 1978 Nov 4;2(8097):968-9.</citation>
    <PMID>81991</PMID>
  </reference>
  <reference>
    <citation>Ben-Menachem T, Fogel R, Patel RV, Touchette M, Zarowitz BJ, Hadzijahic N, Divine G, Verter J, Bresalier RS. Prophylaxis for stress-related gastric hemorrhage in the medical intensive care unit. A randomized, controlled, single-blind study. Ann Intern Med. 1994 Oct 15;121(8):568-75.</citation>
    <PMID>8085688</PMID>
  </reference>
  <reference>
    <citation>Bengmark S, Gianotti L. Nutritional support to prevent and treat multiple organ failure. World J Surg. 1996 May;20(4):474-81. Review.</citation>
    <PMID>8662138</PMID>
  </reference>
  <reference>
    <citation>Craven DE, Steger KA, Barber TW. Preventing nosocomial pneumonia: state of the art and perspectives for the 1990s. Am J Med. 1991 Sep 16;91(3B):44S-53S. Review.</citation>
    <PMID>1928191</PMID>
  </reference>
  <reference>
    <citation>Hatakka K, Savilahti E, Pönkä A, Meurman JH, Poussa T, Näse L, Saxelin M, Korpela R. Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised trial. BMJ. 2001 Jun 2;322(7298):1327.</citation>
    <PMID>11387176</PMID>
  </reference>
  <reference>
    <citation>Fagon JY, Chastre J, Hance AJ, Montravers P, Novara A, Gibert C. Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. Am J Med. 1993 Mar;94(3):281-8.</citation>
    <PMID>8452152</PMID>
  </reference>
  <reference>
    <citation>Holzapfel WH, Haberer P, Geisen R, Björkroth J, Schillinger U. Taxonomy and important features of probiotic microorganisms in food and nutrition. Am J Clin Nutr. 2001 Feb;73(2 Suppl):365S-373S. doi: 10.1093/ajcn/73.2.365s. Review.</citation>
    <PMID>11157343</PMID>
  </reference>
  <reference>
    <citation>Isolauri E. Probiotics in human disease. Am J Clin Nutr. 2001 Jun;73(6):1142S-1146S. Review.</citation>
    <PMID>11393192</PMID>
  </reference>
  <reference>
    <citation>Johanson WG, Pierce AK, Sanford JP. Changing pharyngeal bacterial flora of hospitalized patients. Emergence of gram-negative bacilli. N Engl J Med. 1969 Nov 20;281(21):1137-40.</citation>
    <PMID>4899868</PMID>
  </reference>
  <reference>
    <citation>Johanson WG Jr, Pierce AK, Sanford JP, Thomas GD. Nosocomial respiratory infections with gram-negative bacilli. The significance of colonization of the respiratory tract. Ann Intern Med. 1972 Nov;77(5):701-6.</citation>
    <PMID>5081492</PMID>
  </reference>
  <reference>
    <citation>Johanson WG Jr, Seidenfeld JJ, de los Santos R, Coalson JJ, Gomez P. Prevention of nosocomial pneumonia using topical and parenteral antimicrobial agents. Am Rev Respir Dis. 1988 Feb;137(2):265-72.</citation>
    <PMID>3341620</PMID>
  </reference>
  <reference>
    <citation>Rayes N, Seehofer D, Hansen S, Boucsein K, Müller AR, Serke S, Bengmark S, Neuhaus P. Early enteral supply of lactobacillus and fiber versus selective bowel decontamination: a controlled trial in liver transplant recipients. Transplantation. 2002 Jul 15;74(1):123-7.</citation>
    <PMID>12134110</PMID>
  </reference>
  <reference>
    <citation>Saavedra JM. Clinical applications of probiotic agents. Am J Clin Nutr. 2001 Jun;73(6):1147S-1151S. Review.</citation>
    <PMID>11393193</PMID>
  </reference>
  <reference>
    <citation>Vanderhoof JA. Probiotics: future directions. Am J Clin Nutr. 2001 Jun;73(6):1152S-1155S. Review.</citation>
    <PMID>11393194</PMID>
  </reference>
  <verification_date>March 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 31, 2008</study_first_submitted>
  <study_first_submitted_qc>February 12, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 13, 2008</study_first_posted>
  <last_update_submitted>March 17, 2010</last_update_submitted>
  <last_update_submitted_qc>March 17, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 18, 2010</last_update_posted>
  <responsible_party>
    <name_title>Lee Morrow, MD</name_title>
    <organization>Creighton University Medical Center</organization>
  </responsible_party>
  <keyword>pneumonia</keyword>
  <keyword>ventilator associated pneumonia</keyword>
  <keyword>probiotics</keyword>
  <keyword>Lactobacillus GG</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pneumonia</mesh_term>
    <mesh_term>Pneumonia, Ventilator-Associated</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

